Serum selenium and redox biomarkers show potential to aid in the diagnosis and prognosis of retinal vein occlusion.

Considering this knowledge of the retina, the investigators conducted a study in which the goals were to detect and quantify ...

Retinal artery occlusion was associated with a 1.56-fold increased risk for acute coronary syndrome (relative risk [RR], 1.56; 95% CI, 1.22-1.99) and a twofold increased risk for all-cause mortality ...

This individual participant data meta-analysis aimed to determine whether time to treatment influences the effect of intraarterial thrombolysis (IAT), intravenous thrombolysis, and conservative ...

1 Department of Ophthalmology, The Third People's Hospital of Dalian, Dalian, Liaoning, China 2 Department of Retina, He Eye Specialists Hospital of Shenyang, Shenyang, China Branch retinal vein ...

Background Coronary artery disease (CAD) is linked to an increased risk of mild cognitive impairment (MCI). Effective and ...

The next time you go to bed, take notice of what happens when you flip your room’s light switch. The light doesn’t fade like a sunset or grow duller like a dying campfire. Instead, it cuts instantly ...

This Collection welcomes original research articles that explore clinical, translational and preclinical studies with a focus on pathophysiology, diagnostics, treatment and long-term outcomes. Retinal ...

If approved, EYLEA HD would be the first and only treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period – halving the number of injections that are indicated ...

Regeneron Pharmaceuticals has announced the U.S. FDA's acceptance for Priority Review of the supplemental Biologics License Application for EYLEA HD (aflibercept) Injection 8 mg, which, if approved, ...